Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Kpti    crawled date : 2022 - 02 - 08    save search
Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer
Published: 2022-02-08 (Crawled : 13:00) - prnewswire.com
KPTI | $1.255 -1.95% 620K twitter stocktwits trandingview |
Health Technology
 | | O: -12.31% H: 5.26% C: -4.21%
trial cancer phase 3
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
Published: 2022-02-08 (Crawled : 13:00) - prnewswire.com
KPTI | $1.255 -1.95% 620K twitter stocktwits trandingview |
Health Technology
 | | O: -12.31% H: 5.26% C: -4.21%
financial results report results
Gainers vs Losers
71% 29%

Top 10 Gainers
AGBA | News | $1.27 217.5% 120M twitter stocktwits trandingview |
Finance
EGOX | $0.0503 39.72% 320M twitter stocktwits trandingview |

RWOD | $10.52 31.56% 5.9M twitter stocktwits trandingview |
n/a
ZCMD | $1.905 31.38% 30M twitter stocktwits trandingview |
Commercial Services
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
MRDB 4 | $0.536 27.65% 2M twitter stocktwits trandingview |
n/a
BSFC | $0.0822 27.64% 75M twitter stocktwits trandingview |
Manufacturing
TPET | $0.4121 25.68% 45M twitter stocktwits trandingview |
n/a
INDO | $5.1 25.0% 15M twitter stocktwits trandingview |
Energy Minerals
CHRO | $1.53 24.9% 100K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.